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Background: A hospital is a health service facility that allows nosocomial infections, namely phlebitis. 
Phlebitis is a complication of intravenous catheter placement that is characterized by redness, pain, swelling, 
and fever. The high rate of phlebitis in various countries is due to the risk factors that predispose to the 
incidence of phlebitis due to intravenous catheter placement. 
Objective: This study aims to determine the risk factors for phlebitis in intravenous catheter placement. 
Methodology: This study uses an observational analytic method with a cohort design. The study was 
conducted on 27 February - 14 March 2020 with 22 samples taken using purposive accidental sampling in 
the inward and RST surgery Dr. Soedjono Magelang. The instrument used was an observation sheet 
designed by researchers that had been tested by experts and a standard operational checklist for infusion. 
Data analysis uses a chi-square test and multiple logistic regression. 
Results: The incidence of phlebitis was 7 respondents (31.8%) and the associated risk factors were the 
type of infusion fluid (RR = 4.37 CI 95% 1.09-17.58; p-value 0.020). While the factors of age, sex, nutritional 
status, chronic diseases, types of injection drugs, insertion location, duration of installation, nurse skills, 
installation techniques, and catheter size were not related to the incidence of phlebitis (p-value> 0.05). 
Conclusion: Although  several factors are not related to the incidence of phlebitis, these factors can be a 
support for the incidence of phlebitis. 
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Background. The hospital is a health 
institution that serves the community by 
providing inpatient, outpatient, and emergency 
services (President, 2009). Various hospital 
services from health checks, treatments, and 
even medication can improve the degree of 
public health. However, there are risk factors 
that need to be considered in health care, 
namely nosocomial infections. 
Nosocomial infection or iatrogenic infection 
is an infection obtained after entering a health 
care facility. This is due to the high intensity of 
the patient's illness or frequent invasive actions 
that reduce immunity (Astle et al., 2019). The 
incidence of nosocomial infection is used as a 
standard of service in the accreditation system 
that is ≤1.5% (Rizky, 2016). One contributor to 
nosocomial infections in hospitals is phlebitis. 
Phlebitis is inflammation of venous blood 
vessels due to trauma to the vessel wall, 
infection, immobilization, and duration of IV 
placement (Astle et al., 2019). According to 
Vidhya (2017), phlebitis has signs or symptoms 
such as pain, swelling, redness, and warmth in 
the area of infusion. 
The prevalence of phlebitis is still high in 
some countries. Research in Brazil by 
Urbanetto, Peixoto, & May (2016) explains the 
incidence of phlebitis when a venous catheter 
is 1.25% installed, whereas after an IV has 
been removed 1.38%. Besides, higher phlebitis 
rates occur in the UK reaching 20-80% 
(Mohammed & James, 2018). In Southeast 
Asian countries, the incidence of phlebitis is 
also still high. Research conducted by Gargar, 
Cutamora, & Abocejo (2017) states that the 
incidence of phlebitis in the Philippines is 
12.12% to 23.19%, seen from the time of 
infusion replacement. Whereas in Thailand as 
much as 20% with predictive factors such as 
cancer, smoking, glucose use, and drugs 
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2017). Indonesia, there are no specific data 
regarding phlebitis. However, a study by 
Sumara (2017) at the Husada Utama Hospital 
in Surabaya stated that 56.25% of patients who 
were installed intravenously had phlebitis. 
While the incidence of phlebitis in the 
installation of infusion in Tugurejo Regional 
Hospital Semarang was 55% (Pradini, 2016). 
According to Salgueiro-Oliveira, Parreira, & 
Veiga (2012), risk factors for phlebitis are 
divided into 4 main parts, namely patient 
characteristics, administration of therapy, the 
practice of health professionals, and use of 
materials. On patient characteristic factors 
there are age, sex, nutritional status, illnesses 
suffered by patients (Akbar & Isfiandiari, 2018; 
Rizky & Supriyatiningsih, 2014; Yeesin et al., 
2017). In the age factor, elderly people are 
more at risk of developing phlebitis than 
children so that the incidence of phlebitis in 
pediatric wards is lower (Nadhova, Irasanti, & 
Fitriyana, 2019; Rizky & Supriyatiningsih, 
2014). Factors that include administration of 
therapy are the type of fluid, type of drug 
injected, location of insertion, and length of 
time of installation (Anggita, 2018; Aziz, Hafid, 
& Alip, 2016; Budiarti, Subagja, & Ratnasari, 
2018; Putri, 2016; Sumara, 2017). Practical 
factors of professional health workers include 
nurses 'skills in installation, installation 
techniques, and nurses' knowledge 
(Milutinović, Simin, & Zec, 2015; Nadhova et 
al., 2019), while the factor of material used is 
the type and size of the IV catheter (Milutinović 
et al., 2015). If these factors are not considered 
by nurses in the management of infection 
prevention, the incidence of phlebitis in 
hospitals remains high and even increases. 
The incidence of phlebitis in RST dr. 
Soedjono Magelang Bougenvile, Cempaka, 
and Seruni wards in September to December 
2019 were still quite high, from 2597 patients 
who had infusion as many as 32 patients 
experienced phlebitis and when tested, a value 
of 1.2% was obtained, a number close to the 
hospital nosocomial infection standard 
(≤1.5%). 
Therefore the need to know the most 
dominant risk factors in supporting phlebitis in 
RST dr. Soedjono Magelang so that prevention 
and control of phlebitis can be minimized so 
that the quality of health services in hospitals 
increases. 
Methods. This type of research is an 
observational analytic cohort design. The 
sample in this study was inpatients in the 
Bougenvile, Cempaka, and Seruni Wards 
which were infused and fulfilled the 
researchers' inclusion and exclusion criteria. 
This is with the consideration that the three 
wards have almost the same socio-economic 
conditions that affect the lifestyle of patients 
who support phlebitis. Also, the ward's health 
care form when compared to class 1 or VIP 
wards is slightly different. The sampling 
technique used by researchers is purposive 
accidental sampling, where respondents are 
taken based on the criteria and patient inpatient 
times determined by the researcher. The 
instrument used was an observation sheet 
designed by researchers that had been tested 
by experts and a standard operational checklist 
for infusion. Data analysis uses a chi-square 
test and multiple logistic regression. 
Result and Discussion. Characteristics of 
respondents attached intravenous catheters 
based on age, sex, nutritional status, chronic 
disease, type of infusion fluid, type of drug 
injected, insertion location, duration of 
installation, nurse skills, installation technique, 
size of catheter IV, and incidence of phlebitis in 
the following table 1 
Table 1 Distribution of Characteristics of 
Respondents with Intravenous Catheters  
 
Variable Frequency % 
Age 
≥ 40 years 
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Types of Infusion Fluids 
Risk 


























Duration of Infusion 
>3 days 













































Based on the table the difference in age of 
respondents ≥ 40 years with <40 years by 4 
(18.18%), the sex of women with men as much 
as 2 (9.09%), nutritional status <18.5 kg with ≥ 
18.5 kg as much as 10 (45.45), chronic disease 
predisposing to non-predisposing by 6 
(27.27%), type of infusion fluid with risk not risk 
6 (27.27%), location of joint insertion with non-
joint 8 (36.36 %), duration of infusion 
installation> 3 days with ≤ 3 days was 20 
(90.90), nurse skills ≤ 3 years with> 3 years 
was 8 (36.36%), infusion technique was 4 
(18.18%), catheter size> 20 G with ≤ 20G as 
much as 14 (63.63%), and phlebitis occur 
without 8 (36.36%). 
 


















































































































































































































































































Based on the table, infusion fluid type 
factors influence the incidence of phlebitis with 
a p-value of 0.020 (p-value <0.05), while age, 
sex, nutritional status, chronic diseases, types 
of injection drugs, insertion location, duration of 
infusion, nurse skills, infusion installation 
techniques, and catheter size did not affect the 
incidence of phlebitis with each p-value 0.083; 
0.095; 0.262; 0,166; 0.170; 0.823; 0.484; 
0.655; 0.083; and 0.746 (p-value> 0.05). Even 
so, these factors can predispose to phlebitis by 
looking at the value of Odds Ratio (OR) and 
Relative Risk (RR) in table 2. 
 










2,303 1,057 4,748 1 0,029 10,000 
Age 1,731 1,305 1,760 1 0,185 5,647 
Gender -1,362 1,249 1,190 1 0,275 0,256 
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Based on the table, the most influential 
variable on the incidence of phlebitis is the type 
of infusion fluid with a value of 0.029 with a 
strength of the relationship (OR) of 10.00. 
Research "Risk Factors for Phlebitis” in RST 
Intravenous Catheter dr. Soedjono Magelang 
was held on 27 February 2020 - 14 March 2020 
in the IGD Unit, Bougenvile Ward, Cempaka, 
and Seruni. Researchers could not conduct the 
study within the allotted time (February 24 - 
March 31, 2020) because of the covid19 
pandemic and RST dr. Soedjono became a 
referral for a hospital that treats covid 
patients19 in Central Java. Samples were 
taken using observation sheets and SOP 
checklists that researchers developed 
themselves with a purposive accidental 
sampling technique. 
Samples that researchers took were 
patients aged 18-70 years who were 
hospitalized for at least 2 days and installed 
intravenous catheters, patients treated in the 
Bougenvile, Cempaka, and Seruni wards in 
February-March 2020, the patient had a history 
of previous illnesses, was not diagnosed as 
having a vascular infection and willing to be a 
respondent. 
Age. The results showed that most phlebitis 
occurred in samples aged ≥ 40 years, 6 
respondents (46%) out of 13 respondents 
(100%). This is due to increasing age, more 
fragile blood vessels, decreased cell, and 
tissue regeneration, easy to experience 
increased coagulation, and less effective 
immune system (Fitriyanti, 2015; Putri, 2016; 
Rahmadani, 2018; Rizky & Supriyatiningsih, 
2014). Even so, the results of the chi-square 
test showed that there was no relationship 
between age and phlebitis (p-value 0.083> α 
0.05). This is the same as research conducted 
by Erdogan & Denat (2016); Nito, Setiawati, & 
Murtiningsih (2017); Pradini (2016); Salgueiro-
Oliveira et al. (2012); and Urbanetto et al. 
(2016) which states that age has no 
relationship with the incidence of phlebitis (p-
value> 0.05). 
The results of this study contrast with the 
research of Akbar & Isfiandiari (2018); Fitriyanti 
(2015); Rizky (2016); and Rojas-sánchez, 
Parra, & Camargo-figuera (2015). The study 
revealed that age affects the incidence of 
phlebitis. 
The amount of risk obtained is 6.85 with 
95% CI 0.66-71.72, which means that the age 
factor of 6.85 is at risk of phlebitis. Meanwhile, 
the results of the relative risk analysis used in 
this cohort study were 4.15 (RR value> 1), so 
patients aged ≥ 40 years had a greater risk of 
developing phlebitis compared to patients aged 
<40 years. This is consistent with the 
expression of Carlos and Furtado (2011) in 
Rahmadani (2018), namely the higher the age, 
the higher the incidence of phlebitis. 
Gender. Based on the results of bivariate 
calculations, it was found that phlebitis was 
mostly experienced by someone who was male 
as many as 5 respondents (50%) from 10 
respondents compared to women 2 
respondents (17%) from 12 respondents. 
These results are the same as the research of 
Abdul-Hak & Barros (2014); Nurinda (2017); 
Uslusoy & Cashew (2008); and Zavareh M & 
Ghorbani (2007) which states that the 
incidence of phlebitis is more common in men 
than women with a percentage of more than 
50%. The reason according to Darmawan 
(2008) in Nurinda (2017) is due to the low level 
of men in paying attention to patterns or 
lifestyles so that they are susceptible to 
disease, besides, the presence of the hormone 
estrogen in a woman's body so that it 
strengthens the immune system. 
Therefore, seen from the p-value of 0.095 
which is greater than α 0.05, it can be 
concluded that the sex factor has no 
relationship with the incidence of phlebitis. The 
results of this study are the same as 
researchers Anand et al. (2020); Erdogan & 
Denat (2016); Lee, Kim, & Kim (2019); and Nito 
et al. (2017) which revealed that gender did not 
have a significant relationship with phlebitis. In 
contrast, the results of this study differ from 
those examined by Akbar & Isfiandiari (2018); 
Pattola, Rachmat, & Basri (2013); and Rizky & 
Supriyatiningsih (2014) the study explained 
that there is a sexual related to the incidence of 
phlebitis ie female sex is more risky than male. 
The reason is high mobility, the immunity that 
often decreases after the menstrual cycle, and 
lower muscle mass when compared to men. 
The amount of risk obtained is 0.20 with 
95% CI 0.02-1.42, which means that the sex 
factor is 0.2 times the risk of phlebitis. 
Meanwhile, the results of the relative risk 
analysis used in this cohort study were 0.33 
(RR value <1), so male patients had a greater 
risk of phlebitis than women. 
Nutrition Status. The results showed that 
phlebitis was more common in patients with a 
Body Mass Index ≥ of 18.5 kg, with 4 
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respondents (25%) out of 16 respondents 
(100%). The p- value from the chi-square test 
also shows the number 0.262 which means 
that nutritional status does not affect the 
incidence of phlebitis. (p-value 0.262> α 0.05). 
This is in line with Pradini's research (2016) 
conducted at Tugurejo District Public Hospital 
Semarang which states that nutritional status is 
not related to phlebitis with a p-value of 0.100. 
These results are different from the research 
of Akbar & Isfiandiari (2018); and Prastika F, 
Susilaningsih, & Amir A (2011). The research 
explains that nutritional status influences the 
occurrence of phlebitis with a p-value of 0.007; 
0.001, which means the p-value < α 0.05 Ha is 
accepted. 
The amount of risk obtained is 3.0 with 95% 
CI 0.04-2.36, which means that the nutritional 
status factor is 3.0 times the risk of phlebitis. 
Meanwhile, the results of the relative risk 
analysis used in this cohort study were 2.00 
(RR value> 1), so patients who have a Body 
Mass Index (BMI) <18.5 kg are at greater risk 
of developing phlebitis than patients having an 
IMT ≥ 18.5 kg That is because the body's lack 
of nutrition will reduce endurance so it is 
susceptible to infection (Prastika F et al., 2011). 
Chronic Disease. The results showed that 
phlebitis often occurs in patients with chronic 
diseases predisposing to 4 respondents (50%) 
of 8 respondents (100%). This is same a 
research by Salma, Sarker, Zafrin, & Ahamed 
(2019) which states that phlebitis mostly occurs 
in patients who have a history of Diabetes 
Mellitus and Hypertension with a percentage of 
32.89% and 25%, respectively. The reason is 
the low flow of blood vessels in the peripheral 
tissues so that the immune system decreases, 
the regeneration of the body's cells slows down, 
and the endothelium wall is easily injured 
(Akbar & Isfiandiari, 2018; Fitriyanti, 2015; 
Jirkovsky, Hlavacova, Nikodemova, & Tomova, 
2014; Salma et al. al., 2019). 
Even so, p-value 0.166> α 0.05 which 
means that chronic disease does not affect 
phlebitis. These results are in line with research 
by Gargar et al. (2017); Rizky (2016); Rojas-
sánchez et al. (2015) which states that there is 
no relationship of disease to the incidence of 
phlebitis with p values of 0.524 each; 0.643; 
and 1.494 (p-value> α 0.05). 
In contrast, the results of this study are 
inversely related to research conducted at 
Thailand's Public Hospital by Yeesin et al., 
(2017), the study revealed that there is a 
relationship between cancer and phlebitis with 
a p-value <0.001. Besides, Akbar & Isfiandiari 
(2018) also stated that a history of 
hypertension and diabetes mellitus influenced 
the occurrence of phlebitis with p values 0.01 
and the magnitude of OR respectively 6.18 and 
17.88. 
The amount of risk obtained is 3.66 with 
95% CI 0.55-24.13 which means that the 
chronic disease factor is 3.66 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
2.33 (RR value> 1), so patients who have 
predisposing chronic diseases such as 
Diabetes Mellitus, Hypertension, Cancer, 
Autoimmune, and Kidney Failure are at greater 
risk of developing phlebitis than patients the 
chronic disease is not a predisposition. 
Types of Infusion Fluids. The results 
showed that phlebitis often occurs in patients 
who get intravenous fluids that fall into the 
category of risk (hypertonic such as mannitol; 
drugs in the form of infusion preparations such 
as moxifloxacin, metronidazole, levofloxacin; 
drugs mixed in the infusion such as neuron) as 
many as 5 respondents (63% ) from 8 
respondents (100%). Also, the results of the 
bivariate analysis showed a p-value of 0.020 
which meant that there was a relationship 
between the types of infusion fluids and 
phlebitis. 
This is line a cohort study by Yeesin et al., 
(2017) conducted at Ratchaphipat Hospital in 
Bangkok, Thailand. The study states that the 
type of infusion fluid affects the incidence of 
phlebitis with a p-value of 0.014 <α 0.05 with 
the highest incidence of phlebitis occurring in 
patients receiving 30% hypertonic fluid. The 
reason is that hypertonic fluids and liquids that 
have acidic pH irritate the venous wall so that it 
is easily damaged and causes phlebitis. 
In contrast, research by Pradini (2016) at 
Tugurejo District Public Hospital Semarang 
concluded that the type of infusion fluid was not 
related to the incidence of phlebitis with p 
values of 0.269> α 0.05. 
The amount of risk obtained is 10.00 with 
95% CI 1.26 to 79.34 which means that the 
type of infusion fluid is 10.00 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
4.37 (RR value> 1), so patients who were given 
a type of infusion fluid such as hypertonic 
and/or had a greater acidic pH occurred 
phlebitis than patients who were given infusion 
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fluid therapy instead risk.  
Types of Injection Medications. The 
results showed that phlebitis was more 
common in patients who were given a type of 
diluted injection drug that is as many as 5 
respondents (45%) of 11 respondents (100%). 
While the p-value generated by bivariate 
analysis is 0.170 which means there is no 
relationship between the types of injection 
drugs and the incidence of phlebitis. 
In contrast, research conducted by Yeesin 
et al., (2017) and Anand et al., (2020) states 
that there is a relationship between injection 
drugs and phlebitis with p-values of 0.003 and 
0.00, respectively. This is because drugs such 
as antibiotics or acidic pH are at risk of causing 
phlebitis (Salgueiro-Oliveira et al., 2012; 
Urbanetto et al., 2016). 
The amount of risk obtained is 3.75 with 
95% CI 0.54-26.04 which means that the type 
of injection drug factor is 3.75 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
2.50 (RR value> 1), so patients who were given 
a diluted injection drug type such as 
omeprazole, cefotaxime, ceftriaxone, and 
vinculin belonging to the antibiotic drug were at 
greater risk of developing antibiotics. phlebitis 
compared to non-diluted injection drugs such 
as norages, ranitidine, ondansetron. This is 
because these drugs that are classified as 
antibiotics choose an acidic pH that can irritate 
the walls of blood vessels.  
Location of the Insertion. The results 
showed that phlebitis was more common in 
patients whose insertion sites were not in the 
joints, namely the metacarpal vein of 5 
respondents (33%) out of 15 respondents 
(100%). Besides, based on the bivariate 
analysis p-value was 0.823 which means that 
the insertion location had no relationship with 
phlebitis (p-value> α 0.05). The results of this 
study are in line with research conducted by 
Nito et al., (2017); Lee et al., (2019) and Anand 
et al., (2020) which stated that the location of 
insertion did not have a significant relationship 
with the incidence of phlebitis, evidenced by p-
values of 0.164; 0.202 and 0.082. 
In contrast, the results of research 
conducted by Uslusoy & Cashew (2008) at 
University Hospital Turkey and Sumara (2017) 
at the Husada Utama Hospital stated that there 
was a relationship between the insertion 
location and the p-value values of 0.049 and 
0.02, respectively. The study revealed that 
phlebitis mostly occurred at the insertion site in 
the forearm vein area (56.9%) and the 
metacarpal vein (25%). 
The amount of risk obtained is 1.25 with 
95% CI 0.17-8.87, which means that the 
insertion location factor is 1.25 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
0.85 (RR value <1), so patients who had 
intravenous catheters installed in non-joint 
areas, namely metacarpal veins, had a greater 
risk of phlebitis than patients in joint locations. 
This is possible because the metacarpal vein 
has inadequate tissue and thin skin in the area 
(Alexander, 2014). 
Duration of Installation. The results 
showed that phlebitis often occurs in patients 
who are infused for ≤ 3 days, namely 7 
respondents (33%) of 21 respondents (100%). 
Many respondents experienced phlebitis on 
day 2 and day 3 of installation. This is the same 
as research by Pattola et al., (2013) which 
explains that phlebitis mostly occurs on the 
third day of infusion (36.7%). The reason is that 
the risk of phlebitis is 35% to 65% after 48 
hours of installation (Alexander, 2014; Budiarti 
et al., 2018) 
Bivariate analysis results obtained a p-value 
of 0.484 which means that the length of 
infusion was not related to the incidence of 
phlebitis. This is in line with research by Enes, 
Opitz, Faro, & Pedreira, (2016). Research 
conducted at the Hospital in the Western 
Brazilian Amazon which stated that the length 
of infusion was not significantly related to the 
incidence of phlebitis was evidenced by the 
results of a p-value of 0.796. 
In contrast to research conducted by 
Urbanetto et al., (2016) at the University 
Hospital in The City of Porto Alegre stated that 
the p-value is 0.016, which means the length of 
infusion affects on phlebitis. 
Nurse Skills. The results of the analysis 
found that phlebitis mostly occurs in patients 
who are infused by nurses who have worked 
longer than 3 years, amounting to 5 
respondents (29%) out of 17 respondents 
(100%). The bivariate analysis results obtained 
a p-value of 0.655 which means that the 
nurses' skills seen from the length of time 
working have no relationship with the 
occurrence of phlebitis. 
The results of this study differ from studies 
conducted by Lee et al., (2019) which states 
that the period of experience of nurses 
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influences the incidence of phlebitis with p 
<0.001. The study explained the long period of 
experience of nurses ≥1 to <3 years caused 
more phlebitis which was 43.3%. The reason is 
that if nurses do not have experience in 
performing difficult catheter infusion let alone 
the patient's poor vein condition, will make 
mistakes more than once during an incision so 
that the risk of phlebitis is increased. 
The magnitude of the risk obtained is 1.60 
with 95% CI 0.20-12.69 which means that the 
nurses' skills factor is 1.60 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
1.36 (RR value> 1), so nurses' skills ≤ 3 years 
are at greater risk of phlebitis compared to> 3 
years. 
Installation Techniques. The results 
showed that phlebitis was more common in 
patients who did infusion not according to SOP, 
namely 6 respondents (46%) out of 13 
respondents (100%) whereas in installation 
according to SOP the only phlebitis occurred in 
1 respondent. That is because improper 
infusion techniques such as poor hand hygiene, 
not using handscoon or aseptic principles that 
are not applied will increase the risk of infection, 
especially phlebitis. 
Although the results of the p-value analysis 
did not indicate an association between the 
infusion technique and phlebitis (p-value 
0.083> α0.05). However, research conducted 
by Fitriyanti, (2015) states that the installation 
technique affects the incidence of phlebitis with 
a p-value of 0,000. 
The amount of risk obtained is 6.85 with 
95% CI 0.65 to 71.72, which means that the 
installation technique is 6.85 times the risk of 
phlebitis. Meanwhile, the results of the relative 
risk analysis used in this cohort study were 
4.15 (RR value> 1), so patients who were fitted 
with an SOP-fitting technique were at greater 
risk of developing phlebitis than according to 
the SOP. 
Catheter size. The results showed that 
phlebitis was more common in patients with 
catheter sizes> 20G, 6 respondents (33%) out 
of 18 respondents (100%). These results are 
the same as the study of Yeesin et al., (2017) 
who explained that the incidence of phlebitis 
occurred more at the catheter size of 22G-24G 
with 14.16%. While the results of bivariate 
calculations of researchers amounted to 0.746 
which means there is no relationship between 
the size of the catheter with phlebitis (p-value> 
α0.05). These results are similar to cohort 
studies conducted by Yeesin et al., (2017) and 
Nito et al., (2017) with p values of 1,000 and 
0.118, respectively. 
Inversely with the research of Anand et al., 
(2020) at the Hospital of North-Eastern India. 
The study states that there is an effect between 
the size of the catheter on the incidence of 
phlebitis with a p-value of 0.00. Also, the RR 
value in the study was greater at 18G and 20G 
catheter sizes (RR: 2.46 CI 95% 1.48-4.08). 
The amount of risk obtained is 1.50 (95% CI 
0.12-17.66) which means that the catheter size 
factor is 1.50 times the risk of phlebitis. 
Meanwhile, the results of the relative risk 
analysis used in this cohort study were 1.33 
(RR value> 1), so patients who had an 
intravenous catheter> 20 G had a greater risk 
of developing phlebitis than a size ≤ 20 G. 
The results of multivariate analysis on the 
joint test produced that each variable has a 
value that is not much different, this means that 
the risk factors studied remain a predisposition 
to phlebitis even though there is no most 
prominent value. As for the multivariate 
analysis on 3 risk factors with a value of p <0.25, 
it was found that the type of infusion fluid type 
was the most dominant risk factor supporting 
the incidence of phlebitis 0.029 with a strength 
of the relationship (OR) of 10.00. 
Conclusion and Suggestions.  Risk 
factors that have a relationship or influence on 
the incidence of phlebitis in this study are the 
types of infusion fluids classified as therapeutic 
administration factors (p-value 0.020 <α 0.05) 
with Odds Ratio (OR) values of 10.00 CI 95% 
1,26-79.36 and Risk Relative (RR) value 4.37 
(95% CI 1.09-17.58). Risk factors for age, sex, 
nutritional status, chronic diseases, types of 
injection drugs, insertion location, duration of 
installation, nurse skills, installation techniques, 
and catheter size do not affect the incidence of 
phlebitis due to p-value> 0.05. Even so, these 
factors can be supporting the incidence of 
phlebitis. The most dominant risk factor in 
supporting the occurrence of phlebitis is the 
type of infusion fluid with a value of 0.029 and 
OR 10,000. 
Suggestions for Medical Officers : It is 
expected to apply and pay attention to the 
technique of infusion installation by Operational 
Standards (SOPs) that have been set in the 
hospital. It is expected to increase the 
supervision of patients undergoing infusion in 
areas of the body that are infused so that the 
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risk of phlebitis or other complications can be 
minimized by early detection. 
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